These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8774285)

  • 21. Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception.
    Mathur R; Hayman G; Bansal A; Jenkins J
    Fertil Steril; 2002 Dec; 78(6):1154-8. PubMed ID: 12477503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration.
    Ludwig M; Jelkmann W; Bauer O; Diedrich K
    Hum Reprod; 1999 Oct; 14(10):2437-41. PubMed ID: 10527964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model.
    Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C
    Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent.
    Neulen J; Raczek S; Pogorzelski M; Grunwald K; Yeo TK; Dvorak HF; Weich HA; Breckwoldt M
    Mol Hum Reprod; 1998 Mar; 4(3):203-6. PubMed ID: 9570265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome.
    Ludwig M; Bauer O; Lopens A; Jelkmann W; Diedrich K
    Hum Reprod; 1998 Jan; 13(1):30-2. PubMed ID: 9512224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome.
    Albert C; Garrido N; Mercader A; Rao CV; Remohí J; Simón C; Pellicer A
    Mol Hum Reprod; 2002 May; 8(5):409-18. PubMed ID: 11994537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in serum vascular endothelial growth factor binding profiles and the development of ovarian hyperstimulation syndrome.
    McElhinney B; Ardill J; Caldwell C; Lloyd F; McClure N
    Fertil Steril; 2002 Aug; 78(2):286-90. PubMed ID: 12137864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
    Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade.
    Gómez R; Simón C; Remohí J; Pellicer A
    Endocrinology; 2002 Nov; 143(11):4339-48. PubMed ID: 12399430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.
    van de Lagemaat R; Raafs BC; van Koppen C; Timmers CM; Mulders SM; Hanssen RG
    Endocrinology; 2011 Nov; 152(11):4350-7. PubMed ID: 21896671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys.
    Bishop CV; Lee DM; Slayden OD; Li X
    J Ovarian Res; 2017 Jul; 10(1):41. PubMed ID: 28683759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis.
    Quintana R; Kopcow L; Marconi G; Sueldo C; Speranza G; Barañao RI
    Hum Reprod; 2001 Sep; 16(9):1814-8. PubMed ID: 11527881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
    Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
    J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome.
    D'Ambrogio G; Fasciani A; Monti M; Cattani R; Genazzani AR; Artini PG
    Gynecol Endocrinol; 1999 Oct; 13(5):311-5. PubMed ID: 10599547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
    Wang Q; Yang G; Yang C; Zhan B; Yang R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.
    Gao MZ; Zhao XM; Sun ZG; Hong Y; Zhao LW; Zhang HQ
    Fertil Steril; 2011 Feb; 95(2):673-8. PubMed ID: 21067720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
    Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response.
    Manau D; Balasch J; Jiménez W; Fábregues F; Civico S; Casamitjana R; Creus M; Vanrell JA
    Hum Reprod; 2000 Jun; 15(6):1295-9. PubMed ID: 10831558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.